流通市值:13.95亿 | 总市值:28.06亿 | ||
流通股本:3077.13万 | 总股本:6190.00万 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 194,205,312.22 | 53,019,570.35 | 282,097,719.99 | 184,688,168.88 |
结算备付金 | 0 | 0 | 0 | 0 |
拆出资金 | 0 | 0 | 0 | 0 |
衍生金融资产 | 0 | 0 | 0 | 0 |
应收票据及应收账款 | 160,655,264.12 | 162,050,698.44 | 170,557,875.6 | 185,905,618.88 |
其中:应收票据 | 4,990,399.47 | 3,247,805.08 | 7,123,407.14 | 9,397,931.47 |
应收账款 | 155,664,864.65 | 158,802,893.36 | 163,434,468.46 | 176,507,687.41 |
应收款项融资 | 3,842,088.41 | 3,942,769.7 | 2,651,137.72 | 3,505,671.82 |
预付款项 | 2,102,211.43 | 2,532,485.99 | 2,291,596.61 | 3,592,374.55 |
应收保费 | 0 | 0 | 0 | 0 |
应收分保账款 | 0 | 0 | 0 | 0 |
应收分保合同准备金 | 0 | 0 | 0 | 0 |
其他应收款合计 | 1,777,927.53 | 1,494,681.17 | 1,950,048.94 | 1,283,423.67 |
其中:应收利息 | 0 | 0 | 0 | 0 |
应收股利 | 0 | 0 | 0 | 0 |
买入返售金融资产 | 0 | 0 | 0 | 0 |
存货 | 39,305,397.51 | 41,810,366.98 | 41,381,424.43 | 34,528,256.42 |
合同资产 | 2,246,674.5 | 2,684,295.85 | 3,619,925.84 | 3,562,463.34 |
一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
其他流动资产 | 614,500.13 | 29,358,510.18 | 333,157,246.23 | 297,116,526.42 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 1,161,591,655.85 | 1,159,137,688.26 | 1,180,230,495.91 | 1,207,857,736.86 |
非流动资产: | ||||
发放委托贷款及垫款 | 0 | 0 | 0 | 0 |
债权投资 | 0 | 0 | 0 | 0 |
其他债权投资 | 0 | 0 | 0 | 0 |
长期应收款 | 0 | 0 | 0 | 0 |
长期股权投资 | 470,788.64 | 481,798.68 | 492,932.48 | 519,681.97 |
其他权益工具投资 | 0 | 0 | 0 | 0 |
其他非流动金融资产 | 0 | 0 | 0 | 0 |
投资性房地产 | 0 | 0 | 0 | 0 |
固定资产 | 14,930,259.34 | 13,685,903.89 | 11,055,655.75 | 10,619,742.78 |
在建工程 | 0 | 0 | 0 | 0 |
生产性生物资产 | 0 | 0 | 0 | 0 |
油气资产 | 0 | 0 | 0 | 0 |
使用权资产 | 2,980,520.94 | 3,501,093.16 | 3,946,509.17 | 4,473,426.59 |
无形资产 | 759,308.26 | 642,216.02 | 685,614.2 | 729,012.38 |
开发支出 | 0 | 0 | 0 | 0 |
商誉 | 0 | 0 | 0 | 0 |
长期待摊费用 | 0 | 0 | 0 | 0 |
递延所得税资产 | 3,635,147.71 | 3,523,847.04 | 4,135,629.05 | 3,961,535.82 |
其他非流动资产 | 332,330,096.11 | 322,473,052.13 | 285,939,847.78 | 280,759,750.12 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 355,106,121 | 344,307,910.92 | 306,256,188.43 | 301,063,149.66 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 1,516,697,776.85 | 1,503,445,599.18 | 1,486,486,684.34 | 1,508,920,886.52 |
流动负债: | ||||
短期借款 | 0 | 0 | 0 | 0 |
向中央银行借款 | 0 | 0 | 0 | 0 |
吸收存款及同业存放 | 0 | 0 | 0 | 0 |
拆入资金 | 0 | 0 | 0 | 0 |
交易性金融负债 | 0 | 0 | 0 | 0 |
衍生金融负债 | 0 | 0 | 0 | 0 |
应付票据及应付账款 | 10,953,523.3 | 14,562,999.85 | 13,524,309.24 | 15,553,426.82 |
其中:应付票据 | 1,629,638.18 | 3,218,576.43 | 2,879,129.84 | 2,877,512.44 |
应付账款 | 9,323,885.12 | 11,344,423.42 | 10,645,179.4 | 12,675,914.38 |
预收款项 | 0 | 0 | 0 | 0 |
合同负债 | 9,538,148.36 | 8,194,213.09 | 6,679,481.83 | 2,095,544.95 |
卖出回购金融资产款 | 0 | 0 | 0 | 0 |
应付手续费及佣金 | 0 | 0 | 0 | 0 |
应付职工薪酬 | 7,318,091.1 | 4,293,043.59 | 4,340,817.53 | 15,135,474.18 |
应交税费 | 1,515,498.11 | 647,245.33 | 99,264.35 | 9,332,613.7 |
其他应付款合计 | 1,226,378.79 | 637,094.5 | 380,512.93 | 581,596.64 |
其中:应付利息 | 0 | 0 | 0 | 0 |
应付股利 | 0 | 0 | 0 | 0 |
应付分保账款 | 0 | 0 | 0 | 0 |
保险合同准备金 | 0 | 0 | 0 | 0 |
代理买卖证券款 | 0 | 0 | 0 | 0 |
代理承销证券款 | 0 | 0 | 0 | 0 |
一年内到期的非流动负债 | 2,190,706.93 | 2,266,573.97 | 2,285,332.77 | 2,308,646.93 |
其他流动负债 | 510,252.75 | 447,595.53 | 140,912.03 | 78,322.26 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 33,252,599.34 | 31,048,765.86 | 27,450,630.68 | 45,085,625.48 |
非流动负债: | ||||
长期借款 | 0 | 0 | 0 | 0 |
应付债券 | 0 | 0 | 0 | 0 |
优先股 | 0 | 0 | 0 | 0 |
永续债 | 0 | 0 | 0 | 0 |
租赁负债 | 1,530,730.59 | 2,044,811.21 | 2,522,412.1 | 3,124,506.34 |
长期应付款 | 0 | 0 | 0 | 0 |
长期应付职工薪酬 | 0 | 0 | 0 | 0 |
预计负债 | 0 | 0 | 0 | 0 |
递延收益 | 2,250,626.52 | 1,051,258.24 | 0 | 525,117.86 |
递延所得税负债 | 0 | 0 | 0 | 0 |
其他非流动负债 | 0 | 0 | 0 | 0 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 3,781,357.11 | 3,096,069.45 | 2,522,412.1 | 3,649,624.2 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 37,033,956.45 | 34,144,835.31 | 29,973,042.78 | 48,735,249.68 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 61,900,000 | 61,900,000 | 61,900,000 | 61,900,000 |
其他权益工具 | 0 | 0 | 0 | 0 |
优先股 | 0 | 0 | 0 | 0 |
永续债 | 0 | 0 | 0 | 0 |
资本公积 | 1,101,245,844.04 | 1,101,245,844.04 | 1,101,245,844.04 | 1,101,245,844.04 |
减:库存股 | 0 | 0 | 0 | 0 |
其他综合收益 | 0 | 0 | 0 | 0 |
专项储备 | 0 | 0 | 0 | 0 |
盈余公积 | 30,572,392.21 | 30,572,392.21 | 30,572,392.21 | 30,572,392.21 |
一般风险准备 | 0 | 0 | 0 | 0 |
未分配利润 | 284,776,420.15 | 274,150,887.38 | 261,360,050.49 | 264,974,750.7 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 1,478,494,656.4 | 1,467,869,123.63 | 1,455,078,286.74 | 1,458,692,986.95 |
少数股东权益 | 1,169,164 | 1,431,640.24 | 1,435,354.82 | 1,492,649.89 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 1,479,663,820.4 | 1,469,300,763.87 | 1,456,513,641.56 | 1,460,185,636.84 |
负债和股东权益合计 | 1,516,697,776.85 | 1,503,445,599.18 | 1,486,486,684.34 | 1,508,920,886.52 |
公告日期 | 2024-10-29 | 2024-08-30 | 2024-04-29 | 2024-04-24 |
审计意见(境内) | 标准无保留意见 |